Trial Outcomes & Findings for Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women (NCT NCT02273206)
NCT ID: NCT02273206
Last Updated: 2020-03-12
Results Overview
Comparison of the proportion of patients who were up to date for colorectal cancer, breast cancer and cervical cancer screenings before and after the intervention. (Chart Review)
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
802 participants
Primary outcome timeframe
Baseline - 12 months
Results posted on
2020-03-12
Participant Flow
Among the 802 participants who were recruited for the study, 759 completed the baseline assessment and were randomized to one of the two intervention groups. Two participants were found to be ineligible after randomization and were excluded; as a result, 757 participants are included in the analyses.
Participant milestones
| Measure |
Collaborative Care Intervention (CCI)
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services.
|
Prevention Care Management (PCM) Intervention
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening.
|
|---|---|---|
|
Overall Study
STARTED
|
378
|
379
|
|
Overall Study
COMPLETED
|
353
|
337
|
|
Overall Study
NOT COMPLETED
|
25
|
42
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Some participants did not provide a response for this question.
Baseline characteristics by cohort
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services.
|
Prevention Care Management (PCM) Intervention
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening.
|
Total
n=757 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
56.2 years
STANDARD_DEVIATION 4.3 • n=378 Participants
|
55.8 years
STANDARD_DEVIATION 4.2 • n=379 Participants
|
56.0 years
STANDARD_DEVIATION 4.3 • n=757 Participants
|
|
Sex: Female, Male
Female
|
378 Participants
n=378 Participants
|
379 Participants
n=379 Participants
|
757 Participants
n=757 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=378 Participants
|
0 Participants
n=379 Participants
|
0 Participants
n=757 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
289 Participants
n=378 Participants
|
301 Participants
n=379 Participants
|
590 Participants
n=757 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
89 Participants
n=378 Participants
|
78 Participants
n=379 Participants
|
167 Participants
n=757 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=378 Participants
|
0 Participants
n=379 Participants
|
0 Participants
n=757 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=755 Participants • Some participants did not provide a response for this question.
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=755 Participants • Some participants did not provide a response for this question.
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=755 Participants • Some participants did not provide a response for this question.
|
|
Race (NIH/OMB)
Black or African American
|
82 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
67 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
149 Participants
n=755 Participants • Some participants did not provide a response for this question.
|
|
Race (NIH/OMB)
White
|
19 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
12 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
31 Participants
n=755 Participants • Some participants did not provide a response for this question.
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
0 Participants
n=755 Participants • Some participants did not provide a response for this question.
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
275 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
300 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
575 Participants
n=755 Participants • Some participants did not provide a response for this question.
|
|
Region of Enrollment
United States
|
378 participants
n=378 Participants
|
379 participants
n=379 Participants
|
757 participants
n=757 Participants
|
|
Primary Language
English
|
163 Participants
n=378 Participants
|
167 Participants
n=379 Participants
|
330 Participants
n=757 Participants
|
|
Primary Language
Spanish
|
215 Participants
n=378 Participants
|
212 Participants
n=379 Participants
|
427 Participants
n=757 Participants
|
|
Country of Birth
Born in U.S.
|
142 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
154 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
296 Participants
n=754 Participants • Some participants did not provide a response for this question.
|
|
Country of Birth
Born outside of U.S.
|
235 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
223 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
458 Participants
n=754 Participants • Some participants did not provide a response for this question.
|
|
Marital Status
Married/cohabitating
|
95 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
95 Participants
n=378 Participants • Some participants did not provide a response for this question.
|
190 Participants
n=754 Participants • Some participants did not provide a response for this question.
|
|
Marital Status
Single/divorced/widowed/separated
|
271 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
274 Participants
n=378 Participants • Some participants did not provide a response for this question.
|
545 Participants
n=754 Participants • Some participants did not provide a response for this question.
|
|
Marital Status
Other
|
10 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
9 Participants
n=378 Participants • Some participants did not provide a response for this question.
|
19 Participants
n=754 Participants • Some participants did not provide a response for this question.
|
|
Education
Less than 8 years
|
89 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
81 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
170 Participants
n=752 Participants • Some participants did not provide a response for this question.
|
|
Education
8-11 years
|
113 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
131 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
244 Participants
n=752 Participants • Some participants did not provide a response for this question.
|
|
Education
Completed High School
|
90 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
82 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
172 Participants
n=752 Participants • Some participants did not provide a response for this question.
|
|
Education
Post High School and higher
|
84 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
82 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
166 Participants
n=752 Participants • Some participants did not provide a response for this question.
|
|
Employment
Employed
|
76 Participants
n=378 Participants
|
78 Participants
n=379 Participants
|
154 Participants
n=757 Participants
|
|
Employment
Unemployed
|
102 Participants
n=378 Participants
|
108 Participants
n=379 Participants
|
210 Participants
n=757 Participants
|
|
Employment
Homemaker
|
61 Participants
n=378 Participants
|
59 Participants
n=379 Participants
|
120 Participants
n=757 Participants
|
|
Employment
Other
|
139 Participants
n=378 Participants
|
134 Participants
n=379 Participants
|
273 Participants
n=757 Participants
|
|
Household income
$0 to $9,999
|
258 Participants
n=374 Participants • Some participants did not provide a response for this question.
|
242 Participants
n=373 Participants • Some participants did not provide a response for this question.
|
500 Participants
n=747 Participants • Some participants did not provide a response for this question.
|
|
Household income
$10,000 to $14,999
|
42 Participants
n=374 Participants • Some participants did not provide a response for this question.
|
69 Participants
n=373 Participants • Some participants did not provide a response for this question.
|
111 Participants
n=747 Participants • Some participants did not provide a response for this question.
|
|
Household income
$15,000 or more
|
74 Participants
n=374 Participants • Some participants did not provide a response for this question.
|
62 Participants
n=373 Participants • Some participants did not provide a response for this question.
|
136 Participants
n=747 Participants • Some participants did not provide a response for this question.
|
|
Insurance
Medicaid + Medicare
|
32 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
32 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
64 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Insurance
Medicaid
|
275 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
285 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
560 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Insurance
Medicare
|
17 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
12 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
29 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Insurance
Employer
|
12 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
17 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
29 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Insurance
No insurance
|
41 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
33 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
74 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Years receiving care at the community health center before consent
< 3
|
126 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
138 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
264 Participants
n=754 Participants • Some participants did not provide a response for this question.
|
|
Years receiving care at the community health center before consent
≥ 3
|
251 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
239 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
490 Participants
n=754 Participants • Some participants did not provide a response for this question.
|
|
Patient Health Questionnaire-9 (PHQ9) Score Group
Mild Depression (5-9)
|
104 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
104 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
208 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Patient Health Questionnaire-9 (PHQ9) Score Group
Moderate Depression (10-14)
|
159 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
147 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
306 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Patient Health Questionnaire-9 (PHQ9) Score Group
Moderately Severe Depression (15-19)
|
80 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
102 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
182 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Patient Health Questionnaire-9 (PHQ9) Score Group
Severe Depression (20-27)
|
34 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
26 Participants
n=379 Participants • Some participants did not provide a response for this question.
|
60 Participants
n=756 Participants • Some participants did not provide a response for this question.
|
|
Cancer Screening
Up to date for Colorectal Cancer Screening
|
83 Participants
n=378 Participants
|
102 Participants
n=379 Participants
|
185 Participants
n=757 Participants
|
|
Cancer Screening
Up to date for Breast Cancer Screening
|
166 Participants
n=378 Participants
|
159 Participants
n=379 Participants
|
325 Participants
n=757 Participants
|
|
Cancer Screening
Up to date for Cervical Cancer Screening
|
160 Participants
n=378 Participants
|
158 Participants
n=379 Participants
|
318 Participants
n=757 Participants
|
|
Cancer history
|
28 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
32 Participants
n=376 Participants • Some participants did not provide a response for this question.
|
60 Participants
n=753 Participants • Some participants did not provide a response for this question.
|
|
Hysterectomy
|
84 Participants
n=377 Participants • Some participants did not provide a response for this question.
|
83 Participants
n=374 Participants • Some participants did not provide a response for this question.
|
167 Participants
n=751 Participants • Some participants did not provide a response for this question.
|
|
Smoking Status
Current
|
92 Participants
n=308 Participants • Electronic health record data for this measure is not available for all participants.
|
89 Participants
n=320 Participants • Electronic health record data for this measure is not available for all participants.
|
181 Participants
n=628 Participants • Electronic health record data for this measure is not available for all participants.
|
|
Smoking Status
Former
|
50 Participants
n=308 Participants • Electronic health record data for this measure is not available for all participants.
|
53 Participants
n=320 Participants • Electronic health record data for this measure is not available for all participants.
|
103 Participants
n=628 Participants • Electronic health record data for this measure is not available for all participants.
|
|
Smoking Status
Never
|
166 Participants
n=308 Participants • Electronic health record data for this measure is not available for all participants.
|
178 Participants
n=320 Participants • Electronic health record data for this measure is not available for all participants.
|
344 Participants
n=628 Participants • Electronic health record data for this measure is not available for all participants.
|
|
Comorbid Condition- Asthma
|
124 Participants
n=377 Participants • Electronic health record data for this measure is not available for all participants.
|
123 Participants
n=378 Participants • Electronic health record data for this measure is not available for all participants.
|
247 Participants
n=755 Participants • Electronic health record data for this measure is not available for all participants.
|
|
Comorbid Condition- Hypertension
|
242 Participants
n=377 Participants • Electronic health record data for this measure is not available for all participants.
|
245 Participants
n=378 Participants • Electronic health record data for this measure is not available for all participants.
|
487 Participants
n=755 Participants • Electronic health record data for this measure is not available for all participants.
|
|
Comorbid Condition- Hyperlipidemia
|
220 Participants
n=377 Participants • Electronic health record data for this measure is not available for all participants.
|
209 Participants
n=378 Participants • Electronic health record data for this measure is not available for all participants.
|
429 Participants
n=755 Participants • Electronic health record data for this measure is not available for all participants.
|
|
Comorbid Condition- Diabetes
|
157 Participants
n=377 Participants • Electronic health record data for this measure is not available for all participants.
|
152 Participants
n=378 Participants • Electronic health record data for this measure is not available for all participants.
|
309 Participants
n=755 Participants • Electronic health record data for this measure is not available for all participants.
|
PRIMARY outcome
Timeframe: Baseline - 12 monthsComparison of the proportion of patients who were up to date for colorectal cancer, breast cancer and cervical cancer screenings before and after the intervention. (Chart Review)
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status
Cervical Cancer Screening - Baseline
|
42.3 Percentage (%) of Participants
|
41.7 Percentage (%) of Participants
|
|
Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status
Cervical Cancer Screening - Follow Up
|
61.6 Percentage (%) of Participants
|
64.6 Percentage (%) of Participants
|
|
Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status
Colorectal Cancer Screening - Baseline
|
22.0 Percentage (%) of Participants
|
26.9 Percentage (%) of Participants
|
|
Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status
Colorectal Cancer Screening - Follow Up
|
56.9 Percentage (%) of Participants
|
52.8 Percentage (%) of Participants
|
|
Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status
Breast Cancer Screening - Baseline
|
43.9 Percentage (%) of Participants
|
42.0 Percentage (%) of Participants
|
|
Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status
Breast Cancer Screening - Follow Up
|
66.7 Percentage (%) of Participants
|
66.8 Percentage (%) of Participants
|
PRIMARY outcome
Timeframe: Baseline - 12 monthsMultivariate logistic regression model was used to assess which factors contributed to colorectal cancer screening up to date status.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Assessment of Colorectal Cancer Screening Up to Date Status After Intervention
Up to Date at Baseline
|
22.0 percentage of participants
|
26.9 percentage of participants
|
|
Assessment of Colorectal Cancer Screening Up to Date Status After Intervention
Up to Date at Follow Up
|
56.9 percentage of participants
|
52.8 percentage of participants
|
PRIMARY outcome
Timeframe: Baseline - 12 monthsMultivariate logistic regression model was used to assess which factors contributed to breast cancer screening up to date status
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Assessment of Breast Cancer Screening Up to Date Status After Intervention
Up to Date at Baseline
|
43.9 Percentage of Participants
|
42.0 Percentage of Participants
|
|
Assessment of Breast Cancer Screening Up to Date Status After Intervention
Up to Date at Follow Up
|
66.7 Percentage of Participants
|
66.8 Percentage of Participants
|
PRIMARY outcome
Timeframe: Baseline - 12 monthsMultivariate logistic regression model was used to assess which factors contributed to cervical cancer screening up to date status
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Assessment of Cervical Cancer Screening Up to Date Status After Intervention
Up to Date at Baseline
|
42.3 Percentage of participants
|
41.7 Percentage of participants
|
|
Assessment of Cervical Cancer Screening Up to Date Status After Intervention
Up to Date at Follow Up
|
61.6 Percentage of participants
|
64.6 Percentage of participants
|
PRIMARY outcome
Timeframe: Baseline - 12 monthsPopulation: These data are collected at baseline and 12 months. Not all participants completed all instruments at both time points.
Comparison of change in depression between the CCI and PCM arm before and after intervention. (Self-Report). The Patient Health Questionnaire-9 (PHQ9) is a well-validated measure of Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) criteria for screening and diagnosing depressive episode, assessing severity, and monitoring treatment response. The PHQ9 score ranges from the minimum of 0 (no depression) to the maximum of 27 (severe depression). The detailed PHQ9 scores and corresponding level of depression severity are as follow: 0 (no depression), 1-4 (mild depression), 5-9 (medium-mild depression), 10-14 (moderate depression), 15-19 (moderately severe depression) and 20-27 (severe depression). The mean change in PHQ9 score is the mean of the differences between PHQ9 score at baseline and the PHQ9 score at follow up for all cases in the respective intervention arm; the greater the change in PHQ9 score, the greater the improvement in depression severity.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=306 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=323 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm
Mean PHQ9 Score at Baseline
|
12.90 units on a scale
Standard Deviation 4.22
|
12.96 units on a scale
Standard Deviation 4.08
|
|
Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm
Mean PHQ9 Score at Follow Up
|
8.24 units on a scale
Standard Deviation 6.67
|
7.84 units on a scale
Standard Deviation 6.24
|
|
Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm
Mean Change in PHQ9 Score
|
4.60 units on a scale
Standard Deviation 6.67
|
5.05 units on a scale
Standard Deviation 6.44
|
PRIMARY outcome
Timeframe: Baseline - 6 monthsPopulation: This data is collected at baseline and 6 months. Not all participants completed all instruments at all time points.
The SCL-20 consists of the 20 depression items on a 4-point scale from the SCL-90, and has been shown to be a valid and reliable measure of depression in diverse outpatient and community populations.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=327 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=333 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months
Baseline · No Depression (<0.5)
|
37 Participants
|
43 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months
Baseline · Mild to Moderate Depression (0.5 - 1.7)
|
198 Participants
|
189 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months
Baseline · Severe Depression (> 1.7)
|
92 Participants
|
101 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months
6 month · No Depression (<0.5)
|
100 Participants
|
97 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months
6 month · Mild to Moderate Depression (0.5 - 1.7)
|
137 Participants
|
147 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months
6 month · Severe Depression (> 1.7)
|
55 Participants
|
56 Participants
|
PRIMARY outcome
Timeframe: Baseline - 12 monthsPopulation: This data is collected at baseline and 12 months. Not all participants completed all instruments at all time points.
The SCL-20 consists of the 20 depression items on a 4-point scale from the SCL-90, and has been shown to be a valid and reliable measure of depression in diverse outpatient and community populations.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=327 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=333 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months
Baseline · No Depression (<0.5)
|
37 Participants
|
43 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months
Baseline · Mild to Moderate Depression (0.5 - 1.7)
|
198 Participants
|
189 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months
Baseline · Severe Depression (> 1.7)
|
92 Participants
|
101 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months
12 Months · No Depression (<0.5)
|
113 Participants
|
120 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months
12 Months · Mild to Moderate Depression (0.5 - 1.7)
|
121 Participants
|
141 Participants
|
|
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months
12 Months · Severe Depression (> 1.7)
|
63 Participants
|
50 Participants
|
PRIMARY outcome
Timeframe: Baseline - 12 monthsPopulation: This data is collected at baseline and 12 months. Not all participants completed all instruments at all time points.
Self-Report: We will ask participants about their participation (yes/no) in specific screening methods: Pap testing (past 3 years), mammography (past 2 years), and colorectal screening (fecal occult blood tests (FOBT)/fecal immunohistochemical tests (FIT)), past year; flexible sigmoidoscopy, the past 5 years; and colonoscopy, past 10 years).
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening
Colorectal Cancer Screening - Baseline
|
42.9 Percentage (%) of Participants
|
44.1 Percentage (%) of Participants
|
|
Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening
Colorectal Cancer Screening - Follow Up
|
71.2 Percentage (%) of Participants
|
68.5 Percentage (%) of Participants
|
|
Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening
Breast Cancer Screening - Baseline
|
69.2 Percentage (%) of Participants
|
72.1 Percentage (%) of Participants
|
|
Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening
Breast Cancer Screening - Follow Up
|
89.9 Percentage (%) of Participants
|
87.6 Percentage (%) of Participants
|
|
Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening
Cervical Cancer Screening - Baseline
|
83.3 Percentage (%) of Participants
|
82.2 Percentage (%) of Participants
|
|
Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening
Cervical Cancer Screening - Follow Up
|
87.2 Percentage (%) of Participants
|
90.6 Percentage (%) of Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months for 3 different instruments. Not all participants completed all instruments at all time points.
Participants were asked how many times in the past six months they had seen a provider to talk about or to receive medication for feeling sad, nervous, hopeless, or blue. This question was adapted from the NCI's HINTS survey. Two categories were created using the median as a cut point. The two categories were high utilization and low utilization.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Visits - Baseline · High Utilization
|
162 Participants
|
165 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Visits - Baseline · Low Utilization
|
216 Participants
|
214 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Visits - 6 Months · High Utilization
|
116 Participants
|
136 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Visits - 6 Months · Low Utilization
|
197 Participants
|
190 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Visits - 12 Months · High Utilization
|
125 Participants
|
132 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Visits - 12 Months · Low Utilization
|
191 Participants
|
201 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Prescriptions - Baseline · High Utilization
|
137 Participants
|
145 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Prescriptions - Baseline · Low Utilization
|
241 Participants
|
234 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Prescriptions - 6 Months · High Utilization
|
126 Participants
|
130 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Prescriptions - 6 Months · Low Utilization
|
187 Participants
|
196 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Prescriptions - 12 Months · High Utilization
|
128 Participants
|
135 Participants
|
|
Mental Health Care Utilization: Assessed by Patient Report
Mental Health Prescriptions - 12 Months · Low Utilization
|
188 Participants
|
198 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months for 3 different instruments. Not all participants completed all instruments at all time points.
The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to receive treatment for emotional or mental health and to have cervical, breast, and colon cancer screening.The continuous summary score was converted into two categories using the median as a cut point. The two categories are high satisfaction and low satisfaction.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=374 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=376 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Colorectal Cancer Screening - Baseline · High Satisfaction
|
161 Participants
|
180 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Colorectal Cancer Screening - Baseline · Low Satisfaction
|
212 Participants
|
196 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Colorectal Cancer Screening - 6 months · High Satisfaction
|
112 Participants
|
131 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Colorectal Cancer Screening - 6 months · Low Satisfaction
|
183 Participants
|
170 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Colorectal Cancer Screening - 12 months · High Satisfaction
|
135 Participants
|
148 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Colorectal Cancer Screening - 12 months · Low Satisfaction
|
170 Participants
|
175 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Breast Cancer Screening - Baseline · High Satisfaction
|
186 Participants
|
192 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Breast Cancer Screening - Baseline · Low Satisfaction
|
188 Participants
|
184 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Breast Cancer Screening - 6 months · High Satisfaction
|
147 Participants
|
145 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Breast Cancer Screening - 6 months · Low Satisfaction
|
151 Participants
|
158 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Breast Cancer Screening - 12 months · High Satisfaction
|
150 Participants
|
160 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Breast Cancer Screening - 12 months · Low Satisfaction
|
157 Participants
|
163 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Cervical Cancer Screening - Baseline · High Satisfaction
|
147 Participants
|
152 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Cervical Cancer Screening - Baseline · Low Satisfaction
|
148 Participants
|
142 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Cervical Cancer Screening - 6 months · High Satisfaction
|
99 Participants
|
101 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Cervical Cancer Screening - 6 months · Low Satisfaction
|
122 Participants
|
130 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Cervical Cancer Screening - 12 Months · High Satisfaction
|
107 Participants
|
120 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Cervical Cancer Screening - 12 Months · Low Satisfaction
|
119 Participants
|
131 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Mental Health Care - 12 Months · High Satisfaction
|
129 Participants
|
128 Participants
|
|
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
Mental Health Care - 12 Months · Low Satisfaction
|
175 Participants
|
191 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: Data are collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
This questionnaire, adopted from National Cancer Institute's (NCI) Health Information National Trends Survey (HINTS), assesses whether patients report that their primary care physician 1) has recommended cervical, breast, and colon cancer screening and 2) has recommended that the patient make an appointment with a mental health provider and/or take psychotropic medication. Two categories were created according to whether the patient received a physician recommendation (yes/no). The category of "Recommendation" for when they received a recommendation and a category of "No Recommendation" if they did not receive a recommendation
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Physician Recommendation of Screening/Mental Health Care
Colorectal Cancer Screening - Baseline · Recommendation
|
298 Participants
|
282 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Colorectal Cancer Screening - Baseline · No Recommendation
|
80 Participants
|
96 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Colorectal Cancer Screening - 6 Months · Recommendation
|
281 Participants
|
284 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Colorectal Cancer Screening - 6 Months · No Recommendation
|
23 Participants
|
30 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Colorectal Cancer Screening - 12 Months · Recommendation
|
281 Participants
|
308 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Colorectal Cancer Screening - 12 Months · No Recommendation
|
31 Participants
|
20 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Breast Cancer Screening - Baseline · Recommendation
|
340 Participants
|
339 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Breast Cancer Screening - Baseline · No Recommendation
|
37 Participants
|
37 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Breast Cancer Screening - 6 Months · Recommendation
|
299 Participants
|
303 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Breast Cancer Screening - 6 Months · No Recommendation
|
5 Participants
|
11 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Breast Cancer Screening - 12 Months · Recommendation
|
302 Participants
|
321 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Breast Cancer Screening - 12 Months · No Recommendation
|
10 Participants
|
8 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Cervical Cancer Screening - Baseline · Recommendation
|
309 Participants
|
297 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Cervical Cancer Screening - Baseline · No Recommendation
|
69 Participants
|
79 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Cervical Cancer Screening - 6 Months · Recommendation
|
281 Participants
|
283 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Cervical Cancer Screening - 6 Months · No Recommendation
|
23 Participants
|
31 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Cervical Cancer Screening - 12 Months · Recommendation
|
279 Participants
|
299 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Cervical Cancer Screening - 12 Months · No Recommendation
|
33 Participants
|
28 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Mental Health Care - Baseline · Recommendation
|
206 Participants
|
206 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Mental Health Care - Baseline · No Recommendation
|
172 Participants
|
168 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Mental Health Care - 6 Months · Recommendation
|
183 Participants
|
191 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Mental Health Care - 6 Months · No Recommendation
|
121 Participants
|
122 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Mental Health Care - 12 Months · Recommendation
|
182 Participants
|
203 Participants
|
|
Physician Recommendation of Screening/Mental Health Care
Mental Health Care - 12 Months · No Recommendation
|
130 Participants
|
125 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
This Generalized Anxiety Disorder scale is based on diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) and measures probable anxiety disorder and severity of anxiety symptoms. Patients are asked to rate how often they have been bothered by 7 problems in the last 2 weeks on a 4-point scale. Standard cut points were used for the Generalized Anxiety Disorder measure. Minimal anxiety is (0-4). Mild Anxiety would be count as (5-9). Moderate Anxiety (10-14) and severe anxiety would be (15-21).
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=372 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=372 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Generalized Anxiety Disorder
Baseline · Minimal Anxiety (0-4)
|
79 Participants
|
79 Participants
|
|
Generalized Anxiety Disorder
Baseline · Mild Anxiety (5-9)
|
114 Participants
|
108 Participants
|
|
Generalized Anxiety Disorder
Baseline · Moderate Anxiety (10-14)
|
89 Participants
|
95 Participants
|
|
Generalized Anxiety Disorder
Baseline · Severe Anxiety (15-21)
|
90 Participants
|
90 Participants
|
|
Generalized Anxiety Disorder
6 months · Minimal Anxiety (0-4)
|
133 Participants
|
127 Participants
|
|
Generalized Anxiety Disorder
6 months · Mild Anxiety (5-9)
|
69 Participants
|
82 Participants
|
|
Generalized Anxiety Disorder
6 months · Moderate Anxiety (10-14)
|
61 Participants
|
42 Participants
|
|
Generalized Anxiety Disorder
6 months · Severe Anxiety (15-21)
|
37 Participants
|
50 Participants
|
|
Generalized Anxiety Disorder
12 months · Minimal Anxiety (0-4)
|
124 Participants
|
145 Participants
|
|
Generalized Anxiety Disorder
12 months · Mild Anxiety (5-9)
|
82 Participants
|
77 Participants
|
|
Generalized Anxiety Disorder
12 months · Moderate Anxiety (10-14)
|
46 Participants
|
56 Participants
|
|
Generalized Anxiety Disorder
12 months · Severe Anxiety (15-21)
|
56 Participants
|
44 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
The quality of life was measured with the Medical Outcomes Study (MOS) Short Form Health Survey (SF-12) is a general measure of health status that assess the patient's perceived health status and whether health problems interfere with normal functioning. The SF-12 has demonstrated validity and test-retest reliability in the general population and in patients with chronic health conditions, and has been tested in five languages, including Spanish. It has been used extensively as a quality of life measure in collaborative care studies, including with low-income minority populations. It has also been used frequently in screening studies, for cancer and other conditions. The SF-12 has been validated as an indicator of effects of depression on quality of life in ethnically diverse patients. The continuous summary score was converted into 4 categories using quartiles as cutoff points. The four categories are Best Health, Good health, Fair Health and Worst Health.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=370 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=359 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Medical Outcomes Study Health Survey-Short Form
Baseline · Best Health
|
96 Participants
|
88 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
Baseline · Good Health
|
86 Participants
|
95 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
Baseline · Fair Health
|
92 Participants
|
96 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
Baseline · Worst Health
|
96 Participants
|
80 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
6 months · Best Health
|
70 Participants
|
74 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
6 months · Good Health
|
77 Participants
|
82 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
6 months · Fair Health
|
65 Participants
|
75 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
6 months · Worst Health
|
81 Participants
|
71 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
12 months · Best Health
|
73 Participants
|
83 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
12 months · Good Health
|
79 Participants
|
77 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
12 months · Fair Health
|
72 Participants
|
83 Participants
|
|
Medical Outcomes Study Health Survey-Short Form
12 months · Worst Health
|
83 Participants
|
76 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
This measure was adapted from the National Cancer Institute's HINTS questions for colorectal cancer. The continuous summary score was converted into 4 categories using quartiles as cut points. The categories for screening attitudes were as follows: positive attitudes, moderate attitudes, fair attitudes and negative attitudes.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=377 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=377 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - Baseline · Positive Attitudes
|
71 Participants
|
71 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - Baseline · Moderate Attitudes
|
45 Participants
|
55 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - Baseline · Fair Attitudes
|
161 Participants
|
152 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - Baseline · Negative Attitudes
|
95 Participants
|
95 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 6 months · Positive Attitudes
|
65 Participants
|
64 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 6 months · Moderate Attitudes
|
46 Participants
|
39 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 6 months · Fair Attitudes
|
83 Participants
|
86 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 6 months · Negative Attitudes
|
106 Participants
|
111 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 12 months · Positive Attitudes
|
131 Participants
|
134 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 12 months · Moderate Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 12 months · Fair Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Colorectal Cancer Screening - 12 months · Negative Attitudes
|
177 Participants
|
189 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - Baseline · Positive Attitudes
|
71 Participants
|
79 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - Baseline · Moderate Attitudes
|
62 Participants
|
61 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - Baseline · Fair Attitudes
|
136 Participants
|
132 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - Baseline · Negative Attitudes
|
108 Participants
|
105 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 6 months · Positive Attitudes
|
126 Participants
|
124 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 6 months · Moderate Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 6 months · Fair Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 6 months · Negative Attitudes
|
174 Participants
|
182 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 12 months · Positive Attitudes
|
131 Participants
|
142 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 12 months · Moderate Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 12 months · Fair Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Breast Cancer Screening - 12 months · Negative Attitudes
|
177 Participants
|
183 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - Baseline · Positive Attitudes
|
60 Participants
|
64 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - Baseline · Moderate Attitudes
|
51 Participants
|
58 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - Baseline · Fair Attitudes
|
107 Participants
|
92 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - Baseline · Negative Attitudes
|
82 Participants
|
81 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 6 months · Positive Attitudes
|
99 Participants
|
85 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 6 months · Moderate Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 6 months · Fair Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 6 months · Negative Attitudes
|
124 Participants
|
145 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 12 months · Positive Attitudes
|
98 Participants
|
108 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 12 months · Moderate Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 12 months · Fair Attitudes
|
0 Participants
|
0 Participants
|
|
Breast, Cervical and Colorectal Cancer Screening Attitudes
Cervical Cancer Screening - 12 months · Negative Attitudes
|
129 Participants
|
142 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to have cervical, breast, and colon cancer screening.The satisfaction with decision scale of cancer screening and its continuous summary score was converted into two categories (high satisfaction and low satisfaction) using the median as the cutoff point.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=373 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=376 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10)
Colorectal Cancer Screening - Baseline · High Satisfaction
|
161 Participants
|
180 Participants
|
|
Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10)
Colorectal Cancer Screening - Baseline · Low Satisfaction
|
212 Participants
|
196 Participants
|
|
Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10)
Colorectal Cancer Screening - 6 months · High Satisfaction
|
112 Participants
|
131 Participants
|
|
Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10)
Colorectal Cancer Screening - 6 months · Low Satisfaction
|
183 Participants
|
170 Participants
|
|
Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10)
Colorectal Cancer Screening - 12 Months · High Satisfaction
|
135 Participants
|
148 Participants
|
|
Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10)
Colorectal Cancer Screening - 12 Months · Low Satisfaction
|
170 Participants
|
175 Participants
|
SECONDARY outcome
Timeframe: 12 monthsThe Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to have mental health care.The satisfaction with decision scale of mental health and its continuous summary score was converted into two categories (high satisfaction and low satisfaction) using the median as the cutoff point.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=304 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=319 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10)
High Satisfaction
|
129 Participants
|
128 Participants
|
|
Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10)
Low Satisfaction
|
175 Participants
|
191 Participants
|
SECONDARY outcome
Timeframe: Baseline and 12 monthsPopulation: This data is collected at baseline and 12 months. Not all participants completed this instrument at all time points.
This measure was adapted from the Link's Devaluation-Discrimination Scale.The continuous summary score was converted into 4 categories using quartiles as cut points. The 4 categories were as follows: Low stigma, minimal stigma, moderate stigma and high stigma.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=192 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=193 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Devaluation-Discrimination Scale
Baseline · Low Stigma
|
68 Participants
|
50 Participants
|
|
Devaluation-Discrimination Scale
Baseline · Minimal Stigma
|
42 Participants
|
45 Participants
|
|
Devaluation-Discrimination Scale
Baseline · Moderate Stigma
|
46 Participants
|
49 Participants
|
|
Devaluation-Discrimination Scale
Baseline · High Stigma
|
36 Participants
|
49 Participants
|
|
Devaluation-Discrimination Scale
12 months · Low Stigma
|
50 Participants
|
55 Participants
|
|
Devaluation-Discrimination Scale
12 months · Minimal Stigma
|
36 Participants
|
48 Participants
|
|
Devaluation-Discrimination Scale
12 months · Moderate Stigma
|
30 Participants
|
26 Participants
|
|
Devaluation-Discrimination Scale
12 months · High Stigma
|
44 Participants
|
34 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months. Not all participants completed this instrument at all time points.
The Ambulatory Care Experiences Survey produces 11 summary measures covering 2 broad dimensions of patients' experiences: quality of physician-patient interactions and organizational features of care. The continuous summary score was converted into 4 categories (High, Moderate, Fair and Low) using quartiles as cut-points.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=378 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=379 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - Baseline · High
|
114 Participants
|
123 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - Baseline · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - Baseline · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - Baseline · Low
|
264 Participants
|
256 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 6 Months · High
|
81 Participants
|
77 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 6 Months · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 6 Months · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 6 Months · Low
|
232 Participants
|
249 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 12 Months · High
|
77 Participants
|
108 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 12 Months · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 12 Months · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Shared Decision Making - 12 Months · Low
|
239 Participants
|
225 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - Baseline · High
|
24 Participants
|
23 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - Baseline · Moderate
|
25 Participants
|
22 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - Baseline · Fair
|
23 Participants
|
27 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - Baseline · Low
|
306 Participants
|
307 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 6 Months · High
|
26 Participants
|
30 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 6 Months · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 6 Months · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 6 Months · Low
|
287 Participants
|
296 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 12 Months · High
|
28 Participants
|
26 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 12 Months · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 12 Months · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Access - 12 Months · Low
|
288 Participants
|
307 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - Baseline · High
|
67 Participants
|
61 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - Baseline · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - Baseline · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - Baseline · Low
|
311 Participants
|
318 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 6 Months · High
|
30 Participants
|
19 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 6 Months · Moderate
|
22 Participants
|
22 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 6 Months · Fair
|
23 Participants
|
27 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 6 Months · Low
|
238 Participants
|
258 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 12 Months · High
|
18 Participants
|
26 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 12 Months · Moderate
|
9 Participants
|
4 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 12 Months · Fair
|
39 Participants
|
31 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Care Coordination - 12 Months · Low
|
250 Participants
|
272 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - Baseline · High
|
142 Participants
|
152 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - Baseline · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - Baseline · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - Baseline · Low
|
236 Participants
|
227 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 6 Months · High
|
121 Participants
|
115 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 6 Months · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 6 Months · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 6 Months · Low
|
192 Participants
|
211 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 12 Months · High
|
116 Participants
|
122 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 12 Months · Moderate
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 12 Months · Fair
|
0 Participants
|
0 Participants
|
|
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
Quality - 12 Months · Low
|
200 Participants
|
211 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points
In this questionnaire, respondents were asked if they had been prescribed medication for depression and about difficulties taking medication(s) regularly. Standard cut points was used for medical adherence. High adherence- around an 8. Medium adherence - 6-7.99. Low adherence would be anything less than 6.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=125 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=131 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Medication Adherence
Baseline · High Adherence (8)
|
20 Participants
|
25 Participants
|
|
Medication Adherence
Baseline · Medium Adherence (6-7.99)
|
30 Participants
|
32 Participants
|
|
Medication Adherence
Baseline · Low Adherence (<6)
|
75 Participants
|
74 Participants
|
|
Medication Adherence
6 months · High Adherence (8)
|
20 Participants
|
23 Participants
|
|
Medication Adherence
6 months · Medium Adherence (6-7.99)
|
35 Participants
|
23 Participants
|
|
Medication Adherence
6 months · Low Adherence (<6)
|
60 Participants
|
68 Participants
|
|
Medication Adherence
12 months · High Adherence (8)
|
22 Participants
|
27 Participants
|
|
Medication Adherence
12 months · Medium Adherence (6-7.99)
|
33 Participants
|
31 Participants
|
|
Medication Adherence
12 months · Low Adherence (<6)
|
60 Participants
|
61 Participants
|
SECONDARY outcome
Timeframe: Baseline, 6 months and 12 monthsPopulation: Data are collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
This 5-item scale measures a sense of perceived self-efficacy associated with accessing and paying for the three different types of cancer screening and utilization of needed mental health services. The continuous study score was converted into 4 categories using quartiles as cut points. The 4 categories are high self-efficacy, moderate self- efficacy, minimal self-efficacy and low self-efficacy.
Outcome measures
| Measure |
Collaborative Care Intervention (CCI)
n=373 Participants
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM)
n=373 Participants
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
Baseline · High Self-Efficacy
|
98 Participants
|
87 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
Baseline · Moderate Self-Efficacy
|
87 Participants
|
98 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
Baseline · Minimal Self-Efficacy
|
90 Participants
|
87 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
Baseline · Low Self-Efficacy
|
98 Participants
|
101 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
6 months · High Self-Efficacy
|
70 Participants
|
74 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
6 months · Moderate Self-Efficacy
|
68 Participants
|
76 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
6 months · Minimal Self-Efficacy
|
77 Participants
|
74 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
6 months · Low Self-Efficacy
|
83 Participants
|
80 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
12 months · High Self-Efficacy
|
71 Participants
|
79 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
12 months · Moderate Self-Efficacy
|
81 Participants
|
81 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
12 months · Minimal Self-Efficacy
|
77 Participants
|
79 Participants
|
|
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
12 months · Low Self-Efficacy
|
77 Participants
|
85 Participants
|
Adverse Events
Collaborative Care Intervention (CCI)
Serious events: 1 serious events
Other events: 4 other events
Deaths: 5 deaths
Prevention Care Management (PCM) Intervention
Serious events: 0 serious events
Other events: 4 other events
Deaths: 1 deaths
Serious adverse events
| Measure |
Collaborative Care Intervention (CCI)
n=378 participants at risk
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM) Intervention
n=379 participants at risk
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Vascular disorders
Stroke
|
0.26%
1/378 • Number of events 1 • The adverse event data were collected over the 12 month period in which participants were followed.
|
0.00%
0/379 • The adverse event data were collected over the 12 month period in which participants were followed.
|
Other adverse events
| Measure |
Collaborative Care Intervention (CCI)
n=378 participants at risk
Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services
|
Prevention Care Management (PCM) Intervention
n=379 participants at risk
The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening
|
|---|---|---|
|
Psychiatric disorders
Suicidal Ideation
|
1.1%
4/378 • Number of events 4 • The adverse event data were collected over the 12 month period in which participants were followed.
|
1.1%
4/379 • Number of events 4 • The adverse event data were collected over the 12 month period in which participants were followed.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place